Testicular tumors are both increasing in frequency and disproportionately occur in young men; furthermore, different forms of neoplasm require different treatments. These considerations make the accurate diagnosis of testicular tumors especially important. Many of the critical distinctions involve the differentiation of seminoma from one or more potential mimics because seminoma is not only the most common testicular neoplasm but it is also the only malignant testicular tumor that is commonly treated with radiation, which is ineffective in other malignancies of the testis. For the most part, accurate diagnosis can be achieved by careful light microscopic evaluation, although appropriate immunostains can provide diagnostic assistance if doubt persists. This article discusses a number of clinically important differential diagnoses in the testis that are common sources of misinterpretations. These include: seminoma versus embryonal carcinoma, seminoma versus yolk sac tumor, seminoma versus Sertoli cell tumor, seminoma with syncytiotrophoblast cells versus choriocarcinoma, granulomatous seminoma versus granulomatous orchitis, intertubular seminoma versus orchitis, lymphoma versus seminoma or embryonal carcinoma, dermoid cyst versus teratoma, scar versus regressed germ cell tumor, and ''anaplastic'' spermatocytic seminoma versus usual seminoma or embryonal carcinoma.
A lthough testicular tumors, relative to other forms of neoplasm, are relatively uncommon, they still represent the most frequent solid malignancy in young men between 20 and 30 years of age. Their relative importance, therefore, is magnified because of the numerous years of life that these malignancies put at risk in individual patients. Accurate diagnosis of these tumors is the bedrock for treatment, which often results in cure when optimally configured. Improper treatment based on mistaken interpretations can result in disastrous out-comes. All pathologists, therefore, whether they deal with just a few or many of these cases, must be familiar with certain diagnostic pitfalls. Furthermore, the probability of encountering a testicular tumor is increasing, as a steadily increasing incidence of testicular germ cell tumors (described as an ''epidemic'' in some studies) has been documented throughout the 20th century, with that trend apparently persisting in the 21st. This essay, therefore, will concentrate on what I regard as the most common clinically significant misdiagnoses in testicular tumor pathology, with guidelines for how to avoid them. The selected topics are based on an active consultation service that has permitted an extensive exposure to common misinterpretations. It does not include misinterpretations that have little bearing on treatment and prognosis (as an example, the distinction of embryonal carcinoma from yolk sac tumor) because such distinctions are, for practical purposes, considerably less important. This discussion is structured along the lines of differential diagnosis, and it will become apparent that most of the differentials involve consideration of seminoma. This circumstance is entirely logical because not only is seminoma the single most common form of testicular tumor (representing about 50% of the germ cell tumors and 40% to 45% of testicular neoplasms) it is also the only testicular neoplasm that is commonly treated with radiation, whereas radiation is an ineffective form of management for the other testicular tumors. It therefore is especially important to accurately diagnose seminoma; a false-positive diagnosis of seminoma likely means the patients will receive an ineffective form of treatment, and the misinterpretation of seminoma as a different form of germ cell tumor will often cause the patient to receive chemotherapy with its attendant morbidity, rather than the generally well-tolerated, relatively low-dose radiation employed for most cases of seminoma.
SEMINOMA VERSUS EMBRYONAL CARCINOMA
The distinction of seminoma from embryonal carcinoma is important because early stage seminomas are usually treated with radiation whereas embryonal carcinomas are radiation resistant and are typically managed by combinations of close follow-up (for clinical stage I disease), staging retroperitoneal lymphadenectomy (for clinical stage I disease) or cisplatin-based chemotherapy (for clinical stage II or higher disease). If patients with embryonal carcinoma receive radiation treatment, because of a misinterpretation, it may limit the amount of chemotherapy they can subsequently receive because of the cumulative effects of radiation and chemotherapyrelated bone marrow toxicity.
The prototypical image of seminoma is a tumor having a diffuse arrangement of cells with clear cytoplasm that is further divided into lobules or nests by fibrovascular septa containing lymphocytes, with occasional epithelioid granulomas in some examples. The tumor cells have polygonal nuclei, which often have ''squaredoff'' nuclear edges, with large nucleoli, and the cytoplasmic membranes are typically distinct. 1 In some seminomas, however, the findings do not follow this prototype. In occasional cases, the nuclei may have a diffusely ''smudged'' appearance, although most pathologists successfully recognize such cases as seminoma because of the typical architectural features and continued presence of ancillary features (lymphocytes, granulomas). More problematic are those seminomas where the cytoplasm is denser and amphophilic, the nuclei appear both more irregular and more closely packed, and the cytoplasmic membranes are not uniformly distinct ( Fig. 1A ). 2 In some of these variants, the tumor cells take on a plasmacytoid quality ( Fig. 1B ). 1 The greater nuclear pleomorphism and crowding in these cases, in conjunction with more deeply staining cytoplasm, cause concern for solid pattern embryonal carcinoma, even though the overall architectural pattern usually remains that of seminoma, with fibrovascular septa containing lymphocytes subdividing the tumor into nests.
Work over the past 2 decades supports a model of germ cell tumor histogenesis where seminoma frequently gives rise to embryonal carcinoma, 3, 4 so the changes mentioned might potentially represent such a transformation. The recognition of embryonal carcinoma in this context is straightforward if there is clearcut evidence of epithelial differentiation in the form of glands or papillae. It is unfortunately often subjective, however, when possible transformation of seminoma to solid pattern embryonal carcinoma is considered, largely based on ''too much'' nuclear pleomorphism, crowding, and syncytial cellular appearance (Fig. 1C ). It should parenthetically be mentioned that seminomas often display a degree of nuclear crowding and more densely staining cytoplasm surrounding small punctate foci of necrosis ( Fig. 1D ), and this change should definitely not be overinterpreted as focal transformation to embryonal carcinoma; rather it probably reflects cytolysis adjacent to necrosis, with consequent nuclear crowding and loss of definition of cytoplasmic membranes. If doubt persists concerning the light microscopic evidence for solid embryonal carcinoma in such a case, immunostains can provide helpful and objective evidence for or against such a component ( Table 1 ). Positive staining for both CD30 5 and AE1/AE3 cytokeratin 6 and a negative result for c-kit 7 strongly support a diagnosis of embryonal carcinoma. These results should contrast with those of any light microscopically typical seminoma component. On the basis of my personal experience, most cases of seminoma that have foci of borderline changes for solid embryonal carcinoma lack good immunohistochemical evidence for such transformation; I therefore include them in the spectrum of seminoma. One study recognizes similar cases as ''atypical seminomas'' 2 and provides evidence that they tend to present at a higher tumor stage than morphologically typical seminomas. There are no data, however, to suggest that such tumors require treatment, adjusted for stage, other than for morphologically typical seminoma.
SEMINOMA VERSUS YOLK SAC TUMOR
Solid pattern yolk sac tumor, because of its diffuse pattern of cells with frequently clear cytoplasm ( Fig. 1E ), may mimic seminoma. 1 The distinction of these 2 entities is important for the same reasons mentioned in the discussion concerning seminoma versus embryonal carcinoma. This distinction is usually facilitated by a number of observations, including the more variable nuclear appearance of solid yolk sac tumor ( Fig. 1E ), its lack or at least paucity of lymphocytes and fibrous septa, its frequent association at least with focal microcysts (Fig. 1F ), the occurrence of intracytoplasmic hyaline globules and bandlike deposits of extracellular basement membrane ( Fig. 1F ) in solid yolk sac tumor and, most importantly, the usual occurrence of other distinctive yolk sac tumor patterns. 1, 8 Serum marker studies, if available, may resolve this differential because pure seminomas are not associated with elevation of a-fetoprotein (AFP) (or, at most, are only associated with borderline AFP elevation, 9 ) in contrast to the frequent high levels seen in yolk sac tumors. 10 Although the more typical problem is solid yolk sac tumor mimicking seminoma, the converse situation may also occur. Occasional seminomas may develop a prominent microcystic arrangement that can cause considerable confusion with yolk sac tumor. 11 Although such microcysts may contain edema fluid and show considerable variation in size, features that contrast with the ''cleaner'' spaces seen in yolk sac tumor, some microcystic seminomas have relatively uniform and empty microcystic spaces ( Fig. 2A) , causing significant concern for the possibility of yolk sac tumor. The key finding in these cases, however, is that the cells lining the microcysts retain the typical cytologic features of seminoma, that is-they are uniform, polygonal cells with large nuclei having prominent nucleoli and squared-off nuclear edges. A, This seminoma has dense cytoplasm, poorly defined cytoplasmic membranes, and crowded nuclei, raising concern for solid embryonal carcinoma. B, This seminoma has a plasmacytoid appearance. C, Seminoma (bottom) is juxtaposed to solid embryonal carcinoma; the latter has denser cytoplasm and a syncytial cellular arrangement. D, It is common for seminomas to show increased cytoplasmic density, loss of membrane definition, and crowded nuclei in foci adjacent to necrosis. E, Solid yolk sac tumor with a diffuse arrangement of clear cells causes concern for seminoma; however, the nuclei show greater variation in size and shape than typically seen in seminoma. F, A focal microcystic pattern (upper left) and bands of intercellular basement membrane assist in the recognition of solid yolk sac tumor.
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In contrast, the nuclei of microcystic yolk sac tumors are more pleomorphic and the cells lining the microcysts are often flattened. Additionally, the microcysts in seminoma tend to be separate, whereas in yolk sac tumor there is usually a more complex, interconnecting pattern of microcystic spaces. The ancillary light microscopic features mentioned above remain helpful in this differential diagnosis, although we have noted a definite tendency of seminomas with a prominent microcystic pattern to be relatively lymphocyte poor. 11 If the light microscopic features are equivocal, immunostains can be used to distinguish seminoma from yolk sac tumor ( Table 2 ). Seminomas are negative for AFP and (usually) AE1/AE3 cytokeratin and positive for OCT3/4, 6, 12, 13 Occasional seminomas, especially with the use of modern antigen-retrieval methods and sensitive detection systems, are reactive with AE1/AE3, but such reactivity is usually patchy or ''dotlike'' in the cytoplasm (Fig. 2B ), which contrasts with the strong and diffuse positivity that typifies yolk sac tumor. Yolk sac tumors have opposite reaction patterns for these 3 markers, although it should be mentioned that immunoreactivity for AFP does not occur in all cases of yolk sac tumor, with positive staining in about 75% of cases. 6 Furthermore, positive staining is often patchy, so a negative result, especially in a small specimen, is not helpful. A ''new'' marker, glypican-3, holds promise for this differential; it is reported as uniformly positive in yolk sac tumors and uniformly negative in seminomas in 2 separate studies. 14, 15 SEMINOMA VERSUS SERTOLI CELL TUMOR It is, unfortunately, often not appreciated that Sertoli cell tumor may have a remarkable similarity to seminoma. 16 Malignant Sertoli cell tumors may show a diffuse arrangement of cells with pale to clear cytoplasm in association with a lymphocytic infiltrate ( Fig. 2C ). Distinction of these 2 entities is important because malignant Sertoli cell tumors should be managed by retroperitoneal lymphadenectomy and do not respond to the radiation that is often given for early stage seminoma. Delay in diagnosis may permit an initially curable tumor to disseminate beyond the confines of curative retroperitoneal lymphadenectomy.
The most useful feature to aid in the distinction of clear cell Sertoli cell tumor from seminoma is the nuclear morphology. 16 The Sertoli cell tumors have smaller nuclei with less prominent nucleoli and show fewer mitotic figures than seminomas (Fig. 2D ). Additionally, some may have foci where the cells have a ''rhabdoid'' appearance secondary to eosinophilic cytoplasmic inclusions. The absence of intratubular germ cell neoplasia, unclassified (IGCNU) in Sertoli cell tumor contrasts with its high frequency in the seminiferous tubules adjacent to seminoma. Foci of tubular differentiation are also helpful in raising the possibility of Sertoli cell tumor, but it should be remembered that tubular foci also occur in seminomas. 11, 17, 18 Although the clinical history is not generally useful in the separation of seminoma from Sertoli cell tumor because virtually all initially presenting patients have a solid testicular mass in the absence of serum marker elevation, there are some circumstances where the clinical situation points strongly to a neoplasm other than seminoma. Unfortunately, this is in the context of recurrence when the establishment of the diagnosis of malignant Sertoli cell tumor is often too late for curative management. Nonetheless, a ''red flag'' should be raised whenever the history indicates that a patient with ''seminoma'' has experienced a recurrence either within a previously adequately radiated field or at 3 years or more beyond the orchiectomy and adjuvant radiation. Both of these circumstances are rare; among 950 cases of clinical stage I and II seminomas treated with radiation, only 6 (0.6%) recurred within the radiated field. [19] [20] [21] [22] [23] [24] Furthermore, among 690 patients with seminoma, none experienced recurrence beyond 3 years of initial treatment. 19, 20 The differential of clear cell Sertoli cell tumor versus seminoma can readily be resolved by appropriate immunostains if the potential problem is recognized by light microscopy (Table 3) . Sertoli cell tumors are often positive for inhibin 25 but negative for placental alkaline phosphatase 26 and OCT3/4, whereas seminomas have opposite reactivities. 12, 13 In our experience, about 50% of Sertoli cell tumors are inhibin-negative, so a negative reaction for inhibin is not very helpful.
SEMINOMA WITH SYNCYTIOTROPHOBLAST CELLS VERSUS CHORIOCARCINOMA
It is well known that seminoma may have a component of syncytiotrophoblast cells, which may be conspicuous on occasion. When prominent, clusters of syncytiotrophoblast cells, often with large cytoplasmic lacunae containing blood, admix with seminoma cells (Fig. 2E ). Such cases may mimic choriocarcinoma having an admixture of syncytiotrophoblast cells with cytotrophoblast cells, but the distinction is clinically important as seminoma with syncytiotrophoblast cells is treated as seminoma, but choriocarcinoma is managed with the same approach as for the other nonseminomatous germ cell tumors. A number of features assist in this important differential. First, the syncytiotrophoblast cell clusters tend to be focal in seminoma, with the remaining portions of the tumor showing the typical features of seminoma. On the other hand, choriocarcinoma has a more diffuse, integral syncytiotrophoblast cell component. Additionally, the syncytiotrophoblast cells are admixed with seminoma cells in the seminomatous cases, but with cytotrophoblast or intermediate trophoblast cells in choriocarcinoma. In contrast to seminoma cells, the cytotrophoblast/intermediate trophoblast component has more pleomorphic nuclei and usually denser cytoplasm. In some cases, they may have a fusiform appearance or be distinctly larger than seminoma cells (Fig. 2F) . A greater degree of necrosis is also typically encountered in choriocarcinoma. Unlike seminoma, which typically generates a stroma with a lymphocytic component, choriocarcinoma lacks an associated stroma. Instead it is arranged in nests and sheets that lack both septation and an inflammatory infiltrate. Immunostaining for OCT3/4 is also quite helpful as it highlights seminoma nuclei but is negative in trophoblast cells. 12, 13 
GRANULOMATOUS SEMINOMA VERSUS GRANULOMATOUS ORCHITIS
Although about 50% of seminomas have small, admixed aggregates of epithelioid histiocytes, some seminomas develop a very prominent granulomatous reaction that effaces most of the underlying tumor. Such cases are susceptible to misinterpretation as idiopathic granulomatous orchitis (IGO), 27 even though, despite obliteration of the testicular tumor, metastases may develop, making distinction of these 2 processes critical. IGO is likely an autoimmune disease triggered by initial tubular injury, perhaps of viral nature, that allows immunocompetent cells to gain access to previously masked antigens on spermatozoa and spermatogenic cells. It often, therefore, has a prominent tubular pattern of granulomatous involvement, and this is one of the features that the literature mentions as helping in the differential with granulomatous seminoma. The relative distribution of the granulomatous reaction is said to be more prominent in the interstitium than within the tubules in seminoma, with the reverse pattern in IGO. Although this may be statistically true, I have found it of little value in the assessment of individual cases because of the significant overlap in the distribution of the granulomatous inflammation in these 2 entities; many seminomas have granulomatous reactions in the adjacent tubules (Fig. 3) . More helpful is close inspection of the residual seminiferous tubules for IGCNU, which, if identified, strongly supports seminoma (Fig. 3 ). There is also no substitute for careful scrutiny of these cases for surviving seminoma cells, supplemented by immunostains (OCT3/4, c-kit, placental alkaline phosphatase) if they are not identified by routine light microscopy.
INCONSPICUOUS SEMINOMA VERSUS ORCHITIS
Seminomas may rarely have an exclusively intertubular pattern of growth. 28 Such tumors do not present as mass lesions but may be discovered on biopsy for infertility or during the investigation of metastatic seminoma. In some cases, the affected testis is smaller than normal but ultrasonographic abnormalities are appreciable. A distinct tumor is not grossly apparent in most of these cases, although the testis is often more firm than usual or may show areas of discoloration. Even on microscopic examination its identification may be difficult. Because intertubular seminoma cells frequently provoke the typical lymphocytic reaction, these cases may be misinterpreted as chronic orchitis, especially if the tumor cells are widely scattered rather than clustered in the interstitium (Fig. 4) . In some tumors, the seminoma cells occur within nests of Leydig cells, further masking their presence. In occasional cases of intertubular seminoma, the lymphocytic infiltration is slight to inconspicuous and the tumor cells are dispersed throughout a widened interstitium. The only way to avoid the pitfall of overlooking these cases is to be aware of the possibility of intertubular seminoma whenever a lymphocytic infiltrate is identified in the testis or there are large cells scattered in a prominent interstitium. Close scrutiny for the morphologic features of seminoma cells are indicated in these circumstances. In some cases, prominent foci of IGCNU are more readily appreciable than the invasive tumor and provide a strong clue to the nature of the lesion. Appropriate immunostains (placental alkaline phosphatase, c-kit, OCT3/4) can aid in the recognition of intertubular seminomas. Despite the inconspicuousness of purely intertubular seminomas, there is evidence that this pattern may represent a more aggressive seminoma variant; those seminomas that had foci of intertubular growth that occurred 3 or more high-power fields from the main tumor had a significantly higher frequency of rete testis invasion, 29 which is a finding associated with an increased frequency of relapse in clinical stage I seminomas. 30 
LYMPHOMA VERSUS SEMINOMA OR EMBRYONAL CARCINOMA
Occasional lymphomas in the testis, because of an abundant amount of pale cytoplasm and diffuse arrangement of cells, may have a strong resemblance to seminoma (Fig. 5 ). Although testicular lymphomas often have at least some foci with conspicuous intertubular growth, 31 this may also be a prominent pattern in seminoma, 28 as mentioned above. Additionally, anaplastic large cell lymphomas may have a cohesive appearance and show prominent intratubular growth, sometimes with necrosis of the intratubular component, producing a comedo necrosis pattern (Fig. 6 ). 32 Such tumors mimic embryonal carcinoma with an intratubular component. In both of these circumstances, the nuclear features are helpful in distinguishing lymphoma from either seminoma or solid embryonal carcinoma. The seminomalike lymphomas lack the squared-off nuclei of seminoma and may show a plasmacytoid chromatin. The anaplastic large cell lymphomas show a greater degree of nuclear irregularity than embryonal carcinoma. Furthermore, lymphomas lack IGCNU, in contrast to both seminoma and embryonal carcinoma. Although lymphoma cells may invade into the seminiferous tubules, they do not show the regular basal alignment within the tubules of IGCNU. Immunostains are useful in problematic cases (Table 4 ); testicular lymphomas are often positive for CD45 and CD20 31 or, in the case of anaplastic large cell lymphoma, CD30, and alk-1, but they are negative for OCT3/4 12 and placental alkaline phosphatase. 33 Seminoma and embryonal carcinoma have opposite reaction patterns except, of course, for CD30 reactivity in embryonal carcinoma.
DERMOID CYST VERSUS TERATOMA
Dermoid cysts of the testis are quite rare but they should be separately classified from ''mature teratoma'' because, unlike the latter, they are entirely benign. 34 As a consequence, they are cured by orchiectomy whereas pure ''mature'' teratomas of the testis are associated with metastases of either teratomatous or nonteratomatous germ cell tumor in up to 40% of the cases, according to the literature, [35] [36] [37] a figure that may be inflated secondary to referral bias of treatment centers. Gross examination of dermoids, in some of the reported cases, have an appearance similar to that of ovarian dermoids, with hair and keratinous material in a dominant cyst. Other cases, however, have lacked these helpful gross findings. On microscopic examination, there is a reiteration of normal skin, with stratified squamous epithelium and wellformed hair follicles, sebaceous glands, and sweat glands. Other elements, however, may also occur, including glands lined by enteric-type or ciliated epithelium, cartilage, and well-formed intestinal mucosa. There is a tendency for the teratomatous elements, whether cutaneous or noncutaneous, to be arranged in a wellorganized, organoid fashion. The adjacent parenchyma often has a prominent lipogranulomatous reaction, a finding not seen in my experience with usual teratomas of the testis and likely a consequence of the leakage of sebum-rich, oily material into the parenchyma adjacent to cystic structures. Additional differential features include the complete absence of IGCNU in dermoid cyst of the testis, 34 unlike its usual presence (approximately 90% of cases) in teratoma of the adult testis. 38 Additionally, spermatogenesis is intact elsewhere in the testis, which lacks the widespread atrophy and other ''dysgenetic'' features seen in usual teratomas of the adult testis. Unlike usual teratoma, the cellular elements of dermoids lack any significant cytologic atypia. Although undoubtedly a form of teratoma, dermoid cyst has a totally different pathogenesis from the usual type of teratoma of the adult testis.
The reasons for the difference in the biologic behavior of dermoid cyst and mature teratoma can be explained by a histogenetic model where the latter derives from ''differentiation'' of an invasive nonteratomatous germ cell tumor. 39 This explains the usual association of teratoma with IGCNU, the uncommon occurrence of pure teratoma, and the association of pure teratoma with nonteratomatous metastases. Dermoid cyst, on the other hand, derives from a nontransformed, benign germ cell and therefore lacks all of these associations.
SCAR VERSUS REGRESSED GERM CELL TUMOR
Testicular germ cell tumors are among the most common neoplasms to undergo spontaneous regression.
It is important to distinguish scarring in the testis secondary to a regressed germ cell tumor from that caused by trauma or secondary to vascular disease because patients with regressed tumors may have simultaneous metastases. In fact, the great majority of regressed tumors present with metastases rather than testicular symptoms or findings. 40 A constellation of findings in the testis assists with the diagnosis of a regressed germ cell tumor, including a circumscribed focus of scarring, evidence of testicular dysgenesis in the form of atrophy, impaired spermatogenesis and microlithiasis in the parenchyma surrounding the scar, lymphoplasmacytic infiltrates in the scar, prominent scar vascularity, adjacent IGCNU, prominent, coarse intratubular calcifications, and prominence of Leydig cells ( Fig. 7) . 40 Not all of these features, however, are present in every case. Additionally, it is important to recognize that hyalinized tubular remnants are commonly identified within the scars of regressed germ cell tumors, although, in my experience, many pathologists interpret their presence as evidence for a non-neoplastic scarring process. It is likely that their presence reflects regression of a tumor that had an intertubular pattern of growth, which is common in seminoma. Furthermore, the greatest number of cases of spontaneously regressed germ cell tumors are regressed seminomas. 40 The most specific features for the recognition of a regressed germ cell are association of a scar with either large, coarse intratubular calcifications within the scar (Fig. 8) or IGCNU peripheral to the scar. The former corresponds to dystrophic calcification that develops in the comedo necrosis of intratubular embryonal carcinoma. Unfortunately, these findings are seen in only about 15% and 50%, respectively, of regressed testicular germ cell tumors, 40 so the presence of several of the less specific findings must be relied on for the diagnosis of the other cases.
''ANAPLASTIC'' SPERMATOCYTIC SEMINOMA VERSUS USUAL SEMINOMA OR EMBRYONAL CARCINOMA
The distinction of spermatocytic seminoma from other forms of testicular germ cell tumor (practically speaking, usual seminoma or embryonal carcinoma are the only potential mimics) is important because spermatocytic seminomas (unless complicated by sarcomatous transformation) lack the capacity to metastasize and therefore are adequately treated by orchiectomy alone without any form of adjuvant therapy. [41] [42] [43] [44] Relatively monomorphic examples of spermatocytic seminoma, designated in the literature as anaplastic spermatocytic seminomas, 45 are particularly prone to this pitfall because they have a sheetlike arrangement of large tumor cells with round nuclei, prominent nucleoli, and frequent mitotic figures (Fig. 9 ). Unlike many usual seminomas, the cytoplasm is typically dense and amphophilic rather than clear, and the cell borders poorly defined. Although the nuclei may be crowded, they are less so than those of solid pattern embryonal carcinoma and are also less pleomorphic than those of embryonal carcinoma. Of additional help is the absence of IGCNU in spermatocytic seminoma 46 although these tumors commonly have intratubular growth peripheral to the invasive tumor. This contrasts with the usual presence of IGCNU in both seminoma and embryonal carcinoma. Furthermore, additional sampling of monomorphic spermatocytic seminomas invariably has identified foci with the typical ''tripartite'' cellular population. 45 Immunostains are also valuable, including placental alkaline phosphatase, OCT3/4, AE1/AE3 cytokeratin, and CD30 ( Table 5 ). All of these stains are negative in spermatocytic seminomas 12, 13, 47, 48 whereas they are all positive in embryonal carcinomas; in seminoma, placental alkaline phosphatase and OCT3/4 are positive but not, at least for the most part, AE1/AE3 cytokeratin and CD30. Immunostaining for c-kit is not useful in the distinction of spermatocytic seminoma from usual seminoma because it is frequently positive in both. 49 Positive markers for spermatocytic seminoma include antibodies directed against synovial sarcoma on X chromosome, xeroderma pigmentosum type A protein, and synaptonemal complex protein 1. 50 FIGURE 9 . This spermatocytic seminoma has a monomorphic population of cells with amphophilic cytoplasm, poorly defined cytoplasmic membranes, and crowded nuclei. More characteristic foci were identified elsewhere. 
